The stock of TELA Bio Inc (TELA) has seen a -9.32% decrease in the past week, with a -37.33% drop in the past month, and a -52.12% decrease in the past quarter. The volatility ratio for the week is 5.79%, and the volatility levels for the past 30 days are at 6.79% for TELA. The simple moving average for the past 20 days is -25.29% for TELA’s stock, with a -48.66% simple moving average for the past 200 days.
Is It Worth Investing in TELA Bio Inc (NASDAQ: TELA) Right Now?
TELA has 36-month beta value of 1.02. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for TELA is 16.36M, and currently, short sellers hold a 14.37% ratio of that float. The average trading volume of TELA on August 23, 2024 was 247.23K shares.
TELA) stock’s latest price update
TELA Bio Inc (NASDAQ: TELA) has seen a decline in its stock price by -2.08 in relation to its previous close of 2.88. However, the company has experienced a -9.32% decline in its stock price over the last five trading sessions. seekingalpha.com reported 2024-08-12 that TELA Bio, Inc. (NASDAQ:TELA ) Q2 2024 Results Conference Call August 12, 2024 4:30 PM ET Company Participants Louisa Smith – Vice President of Gilmartin Group Antony Koblish – Co-founder, President & CEO Roberto Cuca – COO & CFO Conference Call Participants Frank Takkinen – Lake Street Capital Markets Caitlin Cronin – Canaccord Genuity Matthew O’Brien – Piper Sandler Michael Sarcone – Jefferies David Turkaly – Citizens JMP Operator Good afternoon, ladies and gentlemen, and welcome to the TELA Bio Second Quarter 2024 Earnings Conference Call. [Operator Instructions].
Analysts’ Opinion of TELA
Many brokerage firms have already submitted their reports for TELA stocks, with Lake Street repeating the rating for TELA by listing it as a “Buy.” The predicted price for TELA in the upcoming period, according to Lake Street is $17 based on the research report published on May 31, 2022 of the previous year 2022.
TELA Trading at -36.18% from the 50-Day Moving Average
After a stumble in the market that brought TELA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -71.43% of loss for the given period.
Volatility was left at 6.79%, however, over the last 30 days, the volatility rate increased by 5.79%, as shares sank -38.16% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -49.47% lower at present.
During the last 5 trading sessions, TELA fell by -8.53%, which changed the moving average for the period of 200-days by -49.02% in comparison to the 20-day moving average, which settled at $3.69. In addition, TELA Bio Inc saw -57.40% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TELA starting from ORBIMED ADVISORS LLC, who sale 378,000 shares at the price of $4.74 back on Jun 28 ’24. After this action, ORBIMED ADVISORS LLC now owns 2,457,542 shares of TELA Bio Inc, valued at $1,791,720 using the latest closing price.
ORBIMED ADVISORS LLC, the 10% Owner of TELA Bio Inc, sale 36,600 shares at $4.54 during a trade that took place back on Jul 02 ’24, which means that ORBIMED ADVISORS LLC is holding 2,407,242 shares at $166,164 based on the most recent closing price.
Stock Fundamentals for TELA
Current profitability levels for the company are sitting at:
- -0.72 for the present operating margin
- 0.69 for the gross margin
The net margin for TELA Bio Inc stands at -0.65. The total capital return value is set at -1.03. Equity return is now at value -196.42, with -54.48 for asset returns.
Based on TELA Bio Inc (TELA), the company’s capital structure generated 0.94 points at debt to capital in total, while cash flow to debt ratio is standing at -1.04. The debt to equity ratio resting at 14.42. The interest coverage ratio of the stock is -8.69.
Currently, EBITDA for the company is -43.27 million with net debt to EBITDA at -0.33. When we switch over and look at the enterprise to sales, we see a ratio of 1.31. The receivables turnover for the company is 6.89for trailing twelve months and the total asset turnover is 1.08. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.41.
Conclusion
To put it simply, TELA Bio Inc (TELA) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
